Your browser doesn't support javascript.
loading
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts.
Harrison, Claire N; Schaap, Nicolaas; Vannucchi, Alessandro M; Kiladjian, Jean-Jacques; Passamonti, Francesco; Zweegman, Sonja; Talpaz, Moshe; Verstovsek, Srdan; Rose, Shelonitda; Zhang, Jun; Sy, Oumar; Mesa, Ruben A.
Afiliação
  • Harrison CN; Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Schaap N; Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands.
  • Vannucchi AM; Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.
  • Kiladjian JJ; Centre d'Investigations Cliniques, INSERM, CIC1427, AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France.
  • Passamonti F; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Talpaz M; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.
  • Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rose S; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Zhang J; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Sy O; Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Mesa RA; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, Texas, USA.
Br J Haematol ; 198(2): 317-327, 2022 07.
Article em En | MEDLINE | ID: mdl-35476316

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mielofibrose Primária Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mielofibrose Primária Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido